You're looking at Less Wrong's discussion board. This includes all posts, including those that haven't been promoted to the front page yet. For more information, see About Less Wrong.

Lumifer comments on 80% of data in Chinese clinical trials have been fabricated - Less Wrong Discussion

6 Post author: DanArmak 02 October 2016 07:38AM

Comments (18)

You are viewing a single comment's thread. Show more comments above.

Comment author: DanArmak 02 October 2016 05:48:42PM 0 points [-]

This raises some interesting questions.

If the end result is fraud and bad medicine, whether you regulate more or less, is that a reason to regulate less so money isn't wasted on mandatory fraudulent studies?

Regulation raises the the barrier of entry to selling medicine. Does this reduce the amount of fraud because it's harder to to sell completely untested medicine and there's at least some quality control by the regulator? Or does it increase the amount of fraud because once a drug costs huge amounts of money to develop and approve, companies are less willing to take a loss if they discover the drug doesn't really work, and so lie more?

Comment author: buybuydandavis 03 October 2016 09:30:10AM 0 points [-]

Don't regulate efficiency. Regulate consistency of formulation, at most.

There are plenty of actors interested in efficacy. Really, everyone else involved.

Comment author: Lumifer 03 October 2016 03:11:04PM 0 points [-]

Don't regulate efficiency. Regulate consistency of formulation, at most.

What's generally regulated is side-effects.